Dr Reddy's launches Reddy-Lenalidomide capsules in Canadian market
Capital MarketDr Reddy's announced that Reddy-Lenalidomide, a generic equivalent to Revlimid (lenalidomide) capsules, is approved by Health Canada and has been launched in the Canadian market. Reddy-Lenalidomide is one of the first generic medications of its kind to launch in Canada.
Reddy-Lenalidomide capsules are available in 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg strengths, each in blister packs.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
